TransMedics Group, Inc.TMDXNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +63.72% | +49.83% | +48.21% | +37.68% | +32.24% |
| Gross Profit Growth | +49.64% | +50.27% | +47.39% | +39.66% | +39.00% |
| EBITDA Growth | +0.00% | +46.66% | +77.87% | +127.68% | +155.93% |
| Operating Income Growth | +0.00% | +232.08% | +120.94% | +192.35% | +493.93% |
| Net Income Growth | +0.00% | +70.11% | +110.56% | +186.26% | +476.83% |
| EPS Growth | +0.00% | +66.67% | +105.41% | +178.38% | +446.15% |
| EPS Diluted Growth | +0.00% | +58.33% | +100.00% | +162.86% | +450.00% |
| Weighted Average Shares Growth | +2.54% | +2.90% | +2.94% | +2.39% | +2.01% |
| Weighted Average Shares Diluted Growth | +9.41% | +3.02% | +15.10% | +14.94% | +14.19% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +136.79% | +0.00% | +256.21% | +914.63% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +4121.69% | +0.00% |
| Receivables Growth | +48.59% | +53.71% | +73.33% | +29.19% | -10.46% |
| Inventory Growth | +32.48% | +5.24% | -10.63% | -20.14% | -14.66% |
| Asset Growth | +13.98% | +13.88% | +15.71% | +17.39% | +20.43% |
| Book Value per Share Growth | +61.89% | +61.92% | +62.23% | +63.60% | +65.88% |
| Debt Growth | +0.48% | +0.45% | +0.42% | +0.45% | +0.23% |
| R&D Expense Growth | -62.79% | +53.00% | +50.79% | +14.98% | +6.97% |
| SG&A Expenses Growth | +39.16% | +35.72% | +20.98% | +3.02% | +7.87% |